José M. Arencibia

HIGH INCIDENCE OF RECEPTORS FOR LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) AND LHRH RECEPTOR GENE EXPRESSION IN HUMAN PROSTATE CANCERS

Gábor Halmos, José M. Arencibia, Andrew V. Schally et al. · The Journal of Urology · 2000 · 161 citations · Full text

Medicine, Endocrinology, Oncology +10

Expression of Growth Hormone-Releasing Hormone (GHRH) Messenger Ribonucleic Acid and the Presence of Biologically Active GHRH in Human Breast, Endometrial, and Ovarian Cancers¹

Zsuzsanna Kahán, José M. Arencibia, Valér Csernus et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 102 citations

Medicine, Endocrinology, Oncology +10

Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site

Katrien Busschots, Laura A. Lopez-Garcia, Carmen Lammi et al. · Chemistry & Biology · 2012 · 82 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma

Christian Schmithals, Verena Köberle, Hüdayi Korkusuz et al. · Cancer Research · 2015 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.

Miklós Koppán, Ahmed Nagy, Andrew V. Schally et al. · PubMed · 1998 · 56 citations · Full text

Medicine, Oncology, Pharmacology +14